Form D · Private Equity Fund

InnovaHealth Partners Fund II, LP

New York, NY · CIK 0001995747

Offering snapshot reported Oct 2, 2026 · SEC filing

Reported sold
$65.3M
Indefinite offering
Investors reported
42
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 3, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$32.6M$65.3MApr 26, 2024Jul 2, 2025: $37,450,000.00Jul 2, 2025Oct 2, 2026: $65,250,000.00Oct 2, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$37,450,000 → $65,250,000
  • Reported investors16 → 42

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 2, 2026Amendment$65,250,000$27,800,000vs Jul 2, 202542SEC filing
Jul 2, 2025Amendment$37,450,000No comparison16SEC filing
Apr 26, 2024InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-511722

Source: Form D, filed Oct 2, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

INNOVAHEALTH PARTNERS FUND II, LP

Investment adviser: INNOVAHEALTH PARTNERS, LP

Gross asset value
$14.7M
Beneficial owners
19
ADV minimum commitment
$0

Reported in Form ADV on Aug 5, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator IQ-EQ DALLAS, Texas, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LLC NEW YORK, New York, United States
Marketer ALDEBARAN ADVISORY SL MADRID, Spain Related to adviser: No
Marketer BOILEAU CONSEIL PARIS, France Related to adviser: No
Marketer MAPLE CREEK ASSETS LTD. TORTOLA, British Virgin Islands Related to adviser: No
Marketer NORTH SEA SECURITIES L.P. NEW YORK, New York, United States Related to adviser: No
Marketer ROSENBLATT SECURITIES INC. NEW YORK, New York, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
Yes
External marketing
Yes

KPMG LLC
PCAOB 185

NORTH SEA SECURITIES L.P.
CRD 35530 · SEC 8-47071

ROSENBLATT SECURITIES INC.
CRD 18377 · SEC 8-24255

Filing source

Form ADV 2116643 · Aug 5, 2026 · Schedule D 7.B.(1), fund 805-8678308451

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mortimer Berkowitz Iii Executive
Ariella Golomb Executive
John Mccormick Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
570 Lexington Avenue, 22 Nd Floor
New York, NY, 10022